Codagenix attracts DOD funding for synthetic biology approach to dengue vaccine By / On August 25, 2022 / At 4:30 pm / In Chemical world 40 Views The firm will get $4 million to develop the jab by modifying viral genomes Post navigation Prev PostFinding new medicines for malaria Next PostEPA updates policy for assessing risks of new chemicals You May Also Like Copolymer could keep catheters bacteria-free On February 4, 2023 | In Chemical world New biosimilar launches to compete against blockbuster drug Humira On February 4, 2023 | In Chemical world Aptamer-based lactate sensor can monitor metabolism On February 4, 2023 | In Chemical world